Loading clinical trials...
Loading clinical trials...
This is a 2-arm, double-blind, parallel, randomized, placebo-controlled clinical study, with 12 weeks of therapy to evaluate the efficacy and safety of DLBS3233 in improving metabolic control in newly...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dexa Medica Group
NCT07512804 · New Onset Diabetes After Transplantation
NCT04528511 · Atrial Fibrillation New Onset, Acute Myocardial Infarction
NCT05169866 · New Onset Atrial Fibrillation, Complications; Cardiac, Postoperative
NCT05287191 · Atrial Fibrillation New Onset
NCT03866148 · Obstructive Sleep Apnea, Cardiovascular Diseases, and more
Division of Endocrinology, Department of Internal Medicine, Dr. Kariadi Hospital
Semarang, Central Java
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions